H.R. 1220: Asthma Inhalers Relief Act of 2013

Introduced:
Mar 15, 2013
Status:
Referred to Committee on Mar 15, 2013
Prognosis
5% chance of being enacted
Track this bill

This bill was assigned to a congressional committee on March 15, 2013, which will consider it before possibly sending it on to the House or Senate as a whole.

Introduced
Mar 15, 2013
Reported by Committee
Passed House
Passed Senate
Signed by the President
 
Sponsor
Michael Burgess
Representative for Texas's 26th congressional district
Party
Republican
Text
Read Text »
Last Updated
Mar 15, 2013
Length
4 pages
Related Bills
H.R. 6190 (112th) was a previous version of this bill.

Failed Under Suspension
Last Action: Dec 12, 2012

 
Full Title

To direct the Administrator of the Environmental Protection Agency to allow for the distribution, sale, and consumption in the United States of remaining inventories of over-the-counter CFC epinephrine inhalers.

Summary

No summaries available.

 
Prognosis

39% chance of getting past committee.
5% chance of being enacted.

Only 11% of bills made it past committee and only about 3% were enacted in 2011–2013. [show factors | methodology]

Cosponsors
3 cosponsors (2D, 1R) (show)
Committees

House Energy and Commerce

Energy and Power

The committee chair determines whether a bill will move past the committee stage.

 
Primary Source

THOMAS.gov (The Library of Congress)

GovTrack gets most information from THOMAS, which is updated generally one day after events occur. Activity since the last update may not be reflected here. Data comes via the congress project.

Widget

Get a bill status widget for your website »

Citation

Click a format for a citation suggestion:

Notes

H.R. stands for House of Representatives bill.

A bill must be passed by both the House and Senate in identical form and then be signed by the president to become law.

The bill’s title was written by its sponsor.

GovTrack’s Bill Summary

We don’t have a summary available yet.

Library of Congress Summary

The summary below was written by the Congressional Research Service, which is a nonpartisan division of the Library of Congress.


3/15/2013--Introduced.
Asthma Inhalers Relief Act of 2013 - Directs the Administrator of the Environmental Protection Agency (EPA) to:
(1) permit the distribution, sale, and consumption in the United States of remaining inventories of CFC epinephrine inhalers manufactured pursuant to the exception for medical devices under the Clean Air Act;
(2) not take any enforcement action or otherwise seek to restrict the distribution, sale, or consumption of such inhalers on the basis of any federal law implementing the Montreal Protocol on Substances that Deplete the Ozone Layer; and
(3) issue, in response to a request of any distributor or seller of such inhalers, a No Action Assurance Letter stating that the EPA will not initiate an enforcement action relating to the distribution or sale of any such inhaler occurring prior to August 1, 2013.
Defines "CFC epinephrine inhaler" to mean any epinephrine inhaler containing chlorofluorocarbons that was manufactured and classified as over-the-counter before January 1, 2012.
Terminates this Act on August 1, 2013.

House Republican Conference Summary

The summary below was written by the House Republican Conference, which is the caucus of Republicans in the House of Representatives.


No summary available.

House Democratic Caucus Summary

The House Democratic Caucus does not provide summaries of bills.

So, yes, we display the House Republican Conference’s summaries when available even if we do not have a Democratic summary available. That’s because we feel it is better to give you as much information as possible, even if we cannot provide every viewpoint.

We’ll be looking for a source of summaries from the other side in the meanwhile.

Use the comment space below for discussion of the merits of H.R. 1220 with other GovTrack users.
Your comments are not read by Congressional staff.

comments powered by Disqus